Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37176 - 37200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	FBXO2	26232	upregulated	entinostat results in increased expression of FBXO2 mRNA	1p36.22	A21037 A21035
Entinostat	Investigational	FBXO9	26268	downregulated	entinostat results in decreased expression of FBXO9 mRNA	6p12.1	A21037
Entinostat	Investigational	FCF1	51077	downregulated	entinostat results in decreased expression of FCF1 mRNA	14q24.3	A21035
Entinostat	Investigational	FDFT1	2222	downregulated	entinostat results in decreased expression of FDFT1 mRNA	8p23.1	A21035
Entinostat	Investigational	FDXR	2232	upregulated	entinostat results in increased expression of FDXR mRNA	17q25.1	A21037
Entinostat	Investigational	FECH	2235	upregulated	entinostat results in increased expression of FECH mRNA	18q21.31	A21035
Entinostat	Investigational	FER1L4	80307	upregulated	entinostat results in increased expression of FER1L4 mRNA	20q11.22	A21035
Entinostat	Investigational	FERMT1	55612	upregulated	entinostat results in increased expression of FERMT1 mRNA	20p12.3	A21037
Entinostat	Investigational	FERMT3	83706	downregulated	entinostat results in decreased expression of FERMT3 mRNA	11q13.1	A21035
Entinostat	Investigational	FEZF2	55079	downregulated	entinostat results in decreased expression of FEZF2 mRNA	3p14.2	A21037
Entinostat	Investigational	FGD5	152273	upregulated	entinostat results in increased expression of FGD5 mRNA	3p25.1	A21037 A21035
Entinostat	Investigational	FGF11	2256	upregulated	entinostat results in increased expression of FGF11 mRNA	17p13.1	A21037 A21035
Entinostat	Investigational	FGF18	8817	upregulated	entinostat results in increased expression of FGF18 mRNA	5q35.1	A21037
Entinostat	Investigational	FGF19	9965	upregulated	entinostat results in increased expression of FGF19 mRNA	11q13.3	A21037
Entinostat	Investigational	FGF2	2247	upregulated	entinostat results in increased expression of FGF2 mRNA	4q28.1	A21037
Entinostat	Investigational	FGF4	2249	upregulated	entinostat results in increased expression of FGF4 mRNA	11q13.3	A21037
Entinostat	Investigational	FGF8	2253	downregulated	entinostat results in decreased expression of FGF8 mRNA	10q24.32	A21037
Entinostat	Investigational	FGF9	2254	downregulated	entinostat results in decreased expression of FGF9 mRNA	13q12.11	A21037 A21035
Entinostat	Investigational	FGFBP3	143282	upregulated	entinostat results in increased expression of FGFBP3 mRNA	10q23.32	A21037
Entinostat	Investigational	FGFR1	2260	upregulated	entinostat results in increased expression of FGFR1 mRNA	8p11.23	A21037
Entinostat	Investigational	FGFR3	2261	upregulated	entinostat results in increased expression of FGFR3 mRNA	4p16.3	A21037
Entinostat	Investigational	FHL1	2273	upregulated	entinostat results in increased expression of FHL1 mRNA	Xq26.3	A21035
Entinostat	Investigational	FHOD1	29109	upregulated	entinostat results in increased expression of FHOD1 mRNA	16q22.1	A21035
Entinostat	Investigational	FIBCD1	84929	upregulated	entinostat results in increased expression of FIBCD1 mRNA	9q34.12	A21037
Entinostat	Investigational	FILIP1	27145	downregulated	entinostat results in decreased expression of FILIP1 mRNA	6q14.1	A21037

Displaying entries 37176 - 37200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability